ArticleMolecular biology of the cell2026
RanBP2-dependent SUMOylation of G3BP2 inhibits formation, and promotes disassembly, of stress granules.
Article in Molecular biology of the cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stress granules and processing bodies (P-bodies) are dynamic cytoplasmic ribonucleoprotein (RNP) condensates that coordinate translation inhibition, mRNA storage, and decay during cellular stress. Emerging evidence suggests that SUMOylation contributes to the regulation of these RNP granules in human cells, though the underlying mechanisms remain largely unexplored. Here, we identify RanBP2-dependent SUMOylation as a key regulator of stress granule and P-body dynamics. Cells that lack RanBP2-mediated SUMOylation show enhanced stress granule assembly and delayed disassembly in response to oxidative stress. We further demonstrate that G3BP2, a core component of stress granules, is SUMOylated in a RanBP2-dependent manner at lysine 281, and that this modification limits spontaneous stress granule formation and promotes efficient disassembly. In addition, the loss of RanBP2-mediated SUMOylation reduces P-body abundance and promotes the merging of a subset of P-bodies with stress granules during stress. Together, our findings suggest that SUMOylation may regulate RNP granules by increasing G3BP solubility, thereby limiting stress granule formation, and by maintaining the balance and segregation of stress granules and P-bodies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.